Search.
65 results for ""
-
The Early Access Voyage – Rare Revolution Spring 2020
Resource -
From kick-off meeting to SIV in five days – a severe COVID-19 pneumonia case-study
Case Study -
A Statement From The Bionical Emas Group On Guidance & Measures Regarding COVID-19
Post -
PharmaMar and Bionical Emas launch Expanded Access Program for lurbinectedin in relapsed Small Cell Lung Cancer in the U.S.
Resource -
Events
Page -
Effective Pharmacovigilance & Regulatory EU and Australian Due Diligence, leading to operational and consultative support
Case Study -
Oxford Hub Launch
Post -
Bionical Emas Regulatory Affairs: Mutual Recognition Submission Strategy
Case Study -
Bionical Emas Global Clinical Operations: Rescue Study
Case Study -
Locally sourcing, storing and distributing comparators and ancillaries for a global phase III study
Case Study -
Global EAP for a specialised Biotech company
Case Study -
European EAP with tailored RWD strategy
Case Study
How can we support you?
Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.